Rohren Eric M
Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, 1400 Pressler - Unit 1483, Houston, TX 77030, USA; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler - Unit 1483, Houston, TX 77030, USA.
PET Clin. 2015 Apr;10(2):243-54. doi: 10.1016/j.cpet.2014.12.006. Epub 2015 Feb 21.
The performance of fludeoxyglucose F 18 (FDG)-PET/computed tomography (CT) in the initial and follow-up evaluation of patients with melanoma is well established. Groups are beginning to investigate whether the inclusion of FDG-PET/CT into a staging or surveillance algorithm results in an improvement in patient outcome and whether such an imaging program would be cost-effective.